Successful therapy of discoid lupus erythematosus with efalizumab

被引：2
|
作者：
Booken, N. [1 ]
Schumann, T. [1 ]
Fuchslocher, M. [1 ]
Goerdt, S. [1 ]
Goebeler, M. [1 ]
机构：
[1] Univ Heidelberg, Med Fak Mannheim, Klin Dermatol Venerol & Allergol, Univ Klinikum Mannheim, D-68135 Mannheim, Germany
来源：
HAUTARZT | 2010年 / 61卷 / 03期
关键词：
Discoid lupus erythematosus; Treatment; Efalizumab;
D O I：
10.1007/s00105-009-1767-4
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
The therapy of discoid lupus erythematosus (DLE) is occasionally a therapeutic challenge. Topical treatment is often not sufficient and therapy with antimalarials [(hydroxy-) chloroquine] not always successful. We report on a 50-year-old male patient with recalcitrant chronic DLE who experienced within 12 weeks at first improvement and then almost complete remission for 11 months after off-label application of the anti-CD11a antibody efalizumab.
引用
收藏
页码：246 / 249
页数：4
相关论文
共 50 条
12345